Skip to main content
. 2025 Jun 12;13(8):e00104-25. doi: 10.1128/spectrum.00104-25

TABLE 1.

NAAT performances for MTBC detection vs culture as reference standard according to the type of samples (n = 685)

Type of sample Number
of samples
NAAT+
/C+
NAAT+
/C−
NAAT-
/C+
NAAT-
/C−
Sensitivity %
(CI 95%)
Specificity %
(CI 95%)
Agreement %
(CI 95%)
Digestive 36 2 1 0 33 100
(15.8–100)
97.1
(84.7–99.9)
97.2
(85.8–99.5)
Lymph nodes 285 19 11 3 252 86.4
(65.1–97.1)
95.8
(92.6–97.9)
95.1
(91.9–97.0)
Bones and joint 113 17 7 1 88 94.4
(83.8–100)
92.6
(85.3–96.9)
92.9
(86.6–96.4)
Serous fluid total 194 3 10 2 179 60.0
(14.6–94.7)
94.7
(90.5–97.4)
93.8
(89.5–96.4)
Cerebrospinal fluid 73 0 7 0 66 N/A 90.4
(81.2–96.1)
N/A
Other serous fluid 13 1 2 0 10 100
(2.5–100)
83.3
(51.6–97.9)
N/A
Ascites fluid 20 1 0 0 19 100
(2.5–100)
100
(84.2–100)
N/A
Pleural fluid 82 1 1 2 78 33.3
(0.84–90.5)
98.7
(93.1–99.9)
N/A
Peritoneal fluid 6 0 0 0 6 N/A 100
(54.1–100)
N/A
Pus 57 10 5 1 41 90.9
(58.7–99.8)
89.1
(76.4–96.4)
89.5
(78.9–95.0)
Total 685a 51 34 7 593 87.9
(76.7–95.0)
94.6
(92.5–96.2)
94.0
(92.0–95.6)
a

Exclusion of invalid tests; C+: MTBC positive culture; C−: MTBC negative culture; NAAT+: Positive ULTRA; NAAT−: Negative ULTRA ; N/A: non-applicable.